Article
A Microphysiological HHT-on-a-Chip Platform Recapitulates Patient Vascular Lesions
2024-03-12
Abstract excerpt
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare congenital disease in which fragile vascular malformations focally develop in multiple organs. These can be small (telangiectasias) or large (arteriovenous malformations, AVMs) and may rupture leading to frequent, uncontrolled bleeding. There are few treatment options and no cure for HHT. Most HHT patients are heterozygous for loss-of-function mutations for End...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ad067064-6202-5e68-8a0f-224d3ebcb5b1
- DOI
- 10.1101/2024.03.11.584490
